ArticleGenomics, proteomics & bioinformatics2025
A Model for the Development of Alzheimer's Disease.
Article in Genomics, proteomics & bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding cancer from the perspective of cellular adaptation to stressors for survival.Quantitative biology (Beijing, China) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracellular alkalosis and extracellular acidosis are well-established characteristics of Alzheimer's disease (AD). We present a computational analysis and modeling of transcriptomic data of AD tissues, aiming to understand their causes and consequences. Our analyses have revealed that (1) persistent mitochondrial alkalization is due to chronic inflammation coupled with elevated iron and copper metabolisms; (2) the affected cells activate multiple acid-producing metabolisms to keep the mitochondrial pH stable for survival; (3) the most significant one is the continuous import and hydrolysis of glutamine to glutamate, NH3, and H+, resulting in persistent release of glutamate, an excitatory neurotransmitter, into the extracellular space; (4) this leads to persistent hyperexcitability of the nearby neurons, resulting in their continuous firing and release of H+-rich synaptic vesicles; (5) the H+ is neutralized by bicarbonates released by the neighboring astrocytes in normal tissues, which could not keep up with the increased the release of H+ in their discharge rates of bicarbonates in AD tissues, leading to progressively increased extracellular acidosis and ultimately cell death; and (6) multiple extensively studied AD-associated phenotypes, including Aβ aggregates and tau fibers, are induced to help to alleviate the pH imbalances and beneficial to cell survival in the early phase of AD, which gradually become contributors to the AD development. Each step in this model is largely supported by published studies. Overall, we have developed a fundamentally novel and systems-level view of how AD may have evolved.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.